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Objectives . The aims of this study were to correlate beta-
endorphin levels and angi pain in patients with inch .
emla induced by rcuta e o us transluminal coronary angioplasty
and to detect eventual endorphin variations during balloon occln-
Rec und. The oploid system appears Involved In the ab .
se of pain occurring in silent myocardial ischemia .
Methods. pieta-endorphin plasma levels were measured 24 h
just before, during and after coronary angioplasty (per-
formed on the left anterior descending artery) in 53 men with
documented coronary artery disease and exercise-Induced myo-
cardial ischemia.
Results. Group 1(33 patients) reported symptoms ; group 2 (20
patients) was asymptomatic during angioplasty . In these patients,
the prevalence of exercise-induced silent ischemia was 57% . The
occurrence of angina during exercise or angioplasty was related to
the frequency of angina during daily life when patients were
su ped. The severity and distribution of coronary artery
Balloon dilation during pcrcutaneous transluminal coronary
angioplasty is an ideal model to induce reversible myocardial
ischemia in patients . The relation between electrical and
clinical manifestations of ischemia induced by decreased
blood supply may be evaluated in the extreme condition of
transient complete vessel occlusion . More often, during
daily life and also during exercise tolerance testing, ischemia
is largely demand-related, is associated with a predominant
sympathetic tone activation and involves subendocardial
layers, whereas coronary angioplasty usually causes trans-
mural ischemia. However, it is more difficult to grade the
degree of myocardial involvement and to control the pro-
voked ischemia during exercise testing than during balloon
dilation at angioplasty
. Studies (1-8) on electrocardiographic
(ECG) changes and their correlations with symptoms have
been conducted in patients during angioplasty . The timing of
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disease did not differ between the two groups. During angioplasty,
the number of balloon inflations and the inflation time and
pressure were similar in symptomatic and asymptomatic patients .
i n each group, no short-term variability of baseline beta-
endorphin plasma levels was observed during 2 consecutive days .
Corresponding beta-endorphin plasma levels (at baseline and
during and after angioplasty) were significantly higher in Group
2. During balloon occlusion, the levels decreased significantly in
the symptomatic group at the onset of angina but remai,wd stable
in the asymptomatic group.
Conclusions. Methodologle variables and the severity of coro-
nary artery disease did not influence the presence of symptoms
during angioplasty-induced ischemia. Beta-endorphin plasma lev-
els were higher and more stable in patients with silent ischemia
during angioplasty, suggesting that opiate levels and their varia-
tion during ischemia are associated with individual attitude to-
ward anginal pain .
fJ Am Coll cordial 1993,22:1614-20)
ECG changes, pail : and wall motion abnormalities have also
been documented (3-$) .
It is well known that spontaneous or provoked myocar-
dial ischemia can occur without pain (9-14), but the expla-
nations for this phenomenon are controversial . Although the
occurrence of pain seems to be related to the duration and
intensity of ischemia and left ventricular dysfunction, these
are not absolute determining factors (11-13,15,16) . The
presence or absence of angina may be partly explained by
individual differences in pain threshold . A generalized hypo-
sensitivity to various pain stimuli has been reported in
patients with silent myocardial ischemia as compared with
the response of symptomatic patients (13,17-19) .
Beta-endorphin, one of the most potent endogenous
opioid-like peptides, is believed to play an important role in
the modulation of pain in the endogenous analgesic system
(a1-23) and appears to be involved in silent myocardial
ischemia as well (24-26) .
The objectives of this study were to determine any
correlation between beta-endorphin plasma levels and the
presence or absence of anginal pain during coronary
angioplasty-induced ischemia, detect eventual beta-
endorphin variations during angioplasty and compare the
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prevalence of symptoms during angioplasty and during ex-
ercise in the same group of patients .
Methods
Fifty-three consecutive men who underwent coronary
angioplasty for clinical indications were studied . The criteria
for inclusion in the study were as follows : 1) reproducible
positive ECG response to an exercise tolerance test ;
2) angiographically documented coronary artery disease ;
3) angioplasty indicated, suitable and successful on a single
vessel (left anterior descending coronary artery) ; 4) coronary
angioplasty--provoked myocardial ischemia (ECG changes)
in areas not involved in previous myocardial infarction ; and
5) consistency of plasm . endorphin values in two determi-
nations performed on each sample .
The study group of 53 patients comprised 41 patients with
coronary artery disease and a history of angina and 12
patients who had never experienced angina . Of the 12
asymptomatic patients, 2 were referred because of a history
of syncope, 6 exhibited silent myocardial ischemia during a
routine physical examination and 4 had silent myocardial
ischemia discovered during a routine postinfarction exami-
nation. Ten patients had a previous (>6 weeks old) myocar-
dial infarction
Exercise-induced myocardial ischemia was documented
in all 53 patients by an ergometric stress test ; it was
associated with pain in 23 patients, whereas 30 patients had
no symptoms. Coronary angiography showed one-vessel
disease in 38 patients, two-vessel disease in 8 and three-
vessel disease in 7 . In all patients, the vessel dilated during
coronary angioplasty was the left anterior descending coro-
nary artery. Mean ejection fraction, calculated by the stan-
dard area-length method, was 64 .2 ± 6.3%. Mean left
ventricular end-diastolic pressure was 12.4 ± 3 .6 mm Hg .
Exercise tolerance test. All patients performed a multi-
stage bicycle ergometric test I to 7 days before coronary
angioplasty . The test was performed in the supine position
with an initial work load of 25 W and subsequent stepwise
increments of 25 W every 3 min at a pedaling frequency of
60 rpm . A 12-lead standard ECG was recorded before the
test, every minute during the test, at the end of exercise and
every minute of recovery . Leads
V4,
Vi and
V6
were
monitored continuously throughout the test . Blood pressure
was measured by means of a standard sphygmomanometer
at 3-min intervals . During the test, patients were asked about
chest pain or discomfort ; when present, it was quantified on
a scale of 1 to 10 and timed in seconds . The test was
terminated when moderate to severe angina, dyspnea, ex-
haustion or >3-mm ST segment depression occurred . A
positive ECG response was defined as the occurrence, for a
0.08-s duration, of flat or downsloping ST segment
depression compared with the baseline tracing. Ischemia
threshold was defined as 1-mm ST segment depression .
Tests were performed in pharmacologic "washout," with
antianginal medication being suspended >24 h before exer-
1615
case ; no patient received beta-adrenergic blocking agents or
digitalis
. Patients with diabetes, systemic hypertension or
neuromuscult,r disease and those whose clinical condition
did not permit temporary withdrawal of antianginal therapy
were excluded from the study .
Coronary arteriography. Arteriography was performed
using the Sones technique I to 15 days before coronary
angioplasty . A 50% stenosis in a major coronary vessel was
defined as significant coronary artery disease .
Fercutoneous transluminal coronary angioplasty . Angio-
plasty was performed by the femoral approach with a Shiley
soft-tip guiding catheter and a MicroHartzler ACS balloon
catheter system or Bonzel Monorail balloon catheter over
0.012 in . (0.015-cm) steerable guide wire . Balloon size
ranged from 2 .5 to 3 mm . Two or more inflations were made,
and pressure was progressively increased (from 2 to 6 atm)
until disappearance of the lesion . Each inflation was moni-
tored for 20 to 60 s . All procedures were performed in the
morning between 9 and I I AM . Patients received 5 mg of
diazepam orally as premedication . All antianginal medica-
tions were stopped a!24 h before coronary angioplasty was
started. Throughout the procedure, a 12-lead ECG was
obtained every 30 s while 6 leads were continuously re-
corded at low (10 mm/s) paper speed on a Mingograf
recorder . Aortic pressure was monitored before, during and
after angioplasty .
Patients were asked during the procedure about the
occurrence of symptoms . If present, symptoms were re-
ported on a graauated linear scale and timed in seconds .
Onset of ST segment displacement and any variations were
carefully observed and calculated independently by two
cardiologists . Coronary angioplasty was performed only on a
single vessel (left anterior descending artery) in each patient ;
successful angioplasty was defined as a diameter gain o" 20°1
without complications .
Beta-endorphin plasma level determination . To determine
beta-endorphin plasma levels, 10-ml venous blood samples
were taken between 9 and I I AM the day before coronary
angioplasty with the patient in a comfortable supine position
and after a rest period of 15 min . On the day of coronary
angioplasty, blood samples were taken (in the catheteriza-
tion laboratory using a peripheral cannula) just before the
procedure (after a rest period of 15 min) and during balloon
inflation at the time of onset of ischemia (and symptoms) .
Another blood sample was taken 15 min after the end of the
procedure . The samples were immediately centrifuged at
4°C, purified by C18 Sep-Pack Cartridges-Waters and ana-
lyzed by a radioimmunoassay method (beta-endorphin-1125,
RIA Kit-Incstar) (26,27) . Each sample was divided in two
and analyzed separately by a different team of pharmacolo-
gists who had no knowledge of the patients' clinical charac-
teristics . Quality control was performed for each determina-
tion . The normal range of beta-endorphin plasma levels in 15
healthy men aged 38 to 70 years was 2
.2 to 7.5 pg/ml (mean
4.3 ± 3 .2). By applying a pulpal test, which is a short
noxious stimulus (18), in the same healthy subjects, the
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following results were obtained: before the test, the mean
plasma level was 4.6 ± 2.9 pg/ml
; during stimulation, it was
5.1 ± 3.4 pg/ml, and 5 min after the test, it was 4
.9
3.1 pg/ml
. Cardiac catheterization did not significantly mod-
ify the baseline beta-endorphin plasma levels in 10 patients
with coronary artery disease who underwent coronary an-
giography without coronary angioplasty; at baseline and
during catheterization, values in these patients were 4 .4 ±
2.3 and 4.7 ± 3.5 pg/ml, respectively .
All patients gave informed consent before the study and
before any procedure . The study protocol was approved by
the Ethics Committee of the hospital .
Statistical analysis . The Kolmogorov-Smirov test was
used to determine whether the studied continuous variables
fit the normal distribution . Because all variables were nor-
mally distributed, it was possible to use pay°amotric tests in
further analyses, An unpaired t test was performed for
analysis of two independent samples . The Mann-Whitney
test was used for two independent nonparametric samples .
To analyze the variations of beta-endorphin plasma levels
in the two patient groups studied (those with [group 1) and
without [group 2) angina during angioplasty-induced isch-
emia), repeated measures analysis of variance was carried
out using the sequential times (at baseline and during and
after coronary angioplasty) as a within-subject factor and
pertaining to group l or 2 as a between-subjects factor . To
focus on the time intervals at which the most relevant
modifications occurred, the contrast among endorphin val-
ues at several times was analyzed (basal levels vs . levels
during angioplasty and the levels during angioplasty vs .
levels after angioplasty in both groups) .
A p value < 0.05 was considered statistically significant .
All analyses were performed with the SPSS/PC+ statistical
package .
Results
Patients were classified into two groups according to the
occurrenen of angina during coronary angioplasty-induced
ischemia. Group I included 33 patients (62%) with anginal
symptoms. Group 2 comprised 20 patients (38%) without
symptoms during balloon dilation .
The mean age was 52 ± 3 years (range 35 to 65) in group
I and 54 ± 2 years (range 38 to 63) in group 2 . Previous
myocardial infarction was diagnosed in six patients (18%) in
group I and four (20%) in group 2 ; in the latter group, the
infarction was always asymptomatic . A history of angina
was present in 32 of the 33 patients in group I and in 9 of the
20 patients in group 2 . All symptomatic patients had class III
or IV angina (Canadian Cardiovascular Society classifica-
tion).
The extent of coronary artery disease was similar in the
two groups-, 22 patients in group 1 and 16 patients in group 2
had single-vessel disease, whereas 9 in group I and 6 in
group 2 had multivessel disease. Ejection fraction and left
ventricular end-diastolic pressure also showed no significant
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differences between the two groups (61 .2 ± 11% vs . 62 .6 -!-
13% and 13 .1 ± 2 vs. 12.1 ± 3 mm Hg, respectively) .
Angioplasty procedures . Groups l and 2 were treated
similarly (p = NS) with respect to the number of balloon
inflations (2.8 ± 1 .4 vs . 3 .1 ± 1 .7), inflation time (76 ± 21 vs .
86 ± 16) and maximal inflation pressure (4.9 ± 2.4 vs . 5 .1
2.1 atm). The mean baseline values of heart rate and blood
pressure were 72 .8 ± 13 beats/min and 132 .8 ± 18 mm Hg,
respectively . During balloon occlusion, they were 85.2 ± 21
beats/min and 146 .6 ± 15 mm Hg, respectively . There was
no statistical difference in mean heart rate and blood pres-
sure between groups I and 2 . The onset of ECG changes was
observed at similar inflation pressures in the two groups of
patients (3 .7 ± 1 .3 vs . 3 .9 ± 1 .4 atm ; p = NS). Electrocar-
diographic abnormalities occurred in 28 patients during the
first balloon inflation, in 12 patients during the second
inflation and in 13 at the third or fourth inflation . The onset
of ST segment shift occurred 27 ± 12 s after balloon inflation
and disappeared 24 ± 10 s after balloon deflation . In group 1,
29 patients exhibited ST segment elevation, averaging 2 .6 ±
0.9 mm, and in 4 patients there was ST depression of
1 .5 ± 1 .2 mm. In group 2, 18 patients had ST elevation of
3.9 ± 1 .8 mm, whereas ST depression of 1 .8 ± 0.9 mm was
present in 2 patients . The ECG changes lasted an average of
23 ± 8 s in group I and 21 ± 9 s in group 2 (p = NS) .
Pain, if present, appeared in all patients at maximal
balloon dilation. The mean time of onset of angina from the
start of inflation was 37 .9 ± 16.4 s . In group 1, the onset of
angina coincided with the appearance of ST segment
changes in 27 patients, but in 5 patients the ECG signs of
ischemia occurred before pain .
Exercise tolerance test . All patients had a positive re-
sponse to exercise tolerance testing as an inclusion criterion .
At the exercise test preceding coronary angioplasty, 23
patients (43%) reported angina and 30 (57%v) had no anginal
y- r.ptoms during exercise-induced myocardial ischemia .
During exercise testing, heart rate and blood pressure at
the ischemia threshold and peak exercise were 112 .9 ± 13
beats/min and 164.3 ± 21 mm Hg and 115.8 ± 19 beats/min
and 170.1 ± 20 mm Hg, respectively . The rate-pressure
product at baseline (9,256 ± 1,123 and 8,993 ± 1,743 mm Hg
x beats/min) and that calculated at ischemia threshold
(1-mm ST segment depression) were similar in the two
groups (18,540 ± 3,562 vs . 18,931 ± 2,643 mm Hg x
beats/min) (p = NS) . Patients with and without symptoms
during exercise-induced myocardial ischemia did not differ
with respect to the extent and distribution of coronary artery
disease .
Twenty-two of the 23 patients who were symptomatic
during exercise were also symptomatic during coronary
angioplasty. Of 30 asymptomatic patients during exercise,
only 10 reported angioplasty-related symptoms and 20 were
asymptomatic. All patients who were symptomatic during
exercise tolerance testing and angioplasty (22 patients) had
reported a history of angina ; I I of 12 patients with pain only
at coronary angioplasty (11 patients) or at exercise testing
JACC Vol . 22, No . 6
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Figure 1 . Beta-endorphin plasma levels in patients with (Group 1)
and without (Group 2) symptoms during coronary angioplasty
(PTCA). Endorphin levels were obtained both 24 h before angio-
plasty and again at baseline conditions just before the procedure . No
short-term variability in beta-endorphin plasma levels was observed
in either group over 2 consecutive days .
(1 patient) had anginal symptoms during normal daily life,
whereas 8 of 19 patients with silent ischemia both at exercise
testing and angioplasty had a previous history of angina . Of
the 12 patients who were asymptomatic during everyday life,
all remained asymptomatic during exercise testing ; I I of
these 12 patients were also symptomless during angioplasty .
'Beta-endorphin plasma levels . In each group, baseline
beta-endorphin plasma levels on the 2 consecutive days of
analysis were similar (Fig . 1) . However, baseline levels were
higher (6.72 t 2 .42 pg1ml) in asymptomatic patients than in
those with symptoms during coronary angioplasty (4 .10
1 .95 pg1ml) (p < 0 .001) (Fig . 2) .
The mean beta-endorphin plasma levels in group 2 re-
mained significantly higher (p < 0 .001) during and after the
procedure (6 .60 ± 2.80 pg/ml, 7 .10 ± 3 .60 pg/ml, respec-
tively) compared with corresponding levels in group I
Figure 2. Beta-endorphin plasma levels in symptomatic (Group I)
and asymptomatic (Group 2) patients before, during and after
coronary angiopla ., ty (PTCA) . The asymptomatic patients showed
higher opiate levels during basal conditions, during balloon occlu-
sion and after the procedure as compared with patients in Group I -
24 hoUre before PICA
baseline just beiore
PICA
Group I
Group 2
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Figure 3 . Beta-endorphin plasma levels decreased significantly in
symptomatic patients (Group I) during coronary angioplasty
(PTCA) but remained more stable in asymptornatic patients (Group
2) . After angiopla%ty, the levels tended to increase in both groups
but to a significant degree only in the asymptomatic group
.
(3.00 ± 1 .84 pg/ml and 3 .60 ± 2.45 pg/ml, respectively) (Fig .
2). Beta-endorphin plasma levels had a different temporal
trend in the two groups. During coronary angioplasty,
plasma levels decreased in both groups, but the reduction
was significant only in patients in group I -, during recovery,
the levels tended to increase to preangioplasty values in both
groups. Analysis of variance confirmed that the temporal
trend was different in the two groups (F
2,47
= 2.98 p < 0.05)
(Fig . 3); the analysis of contrasts underlined that significant
variations occurred during angioplasty in group I (p < 0.05),
whereas beta-endorphin plasma levels were stable during
and after angioplasty in group 2 (Fig . 3) .
By subgrouping the patients according to the occurrence
of symptoms during exercise tolerance testing and coronary
angioplasty, three groups were defined : 22 patients with
angina at both exercise testing and angioplasty, 12 patients
with a mixed profile (symptoms at either angioplasty or
exercise testing but not both) and 19 patients with no
symptoms (during both exercise testing and angioplasty) .
The highest baseline mean opiate level was found in the
group with no symptoms (7.05 ± 3 .7 pg1ml), the lowest level
in the group with symptoms during both the exercise testing
and angioplasty (3 .01 ± 1 .72 pg/ml) and an intermediate level
in the group with a mixed profile (5 .63 ± 3 .3 pg/ml) . During
angioplasty, the difference between the three groups re-
mained statistically significant ; the intragroup variation dur-
ing the procedure, though more marked in the group wit
mixed findings, did not achieve statistical significance .
I
Discussion
The prevalence of silent myocardial ischemia during
coronary angioplasty varies froAi 16% to 47% (2,4,6,8) . in
__ -
Group t
Amp 2
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our study, 38% of the patients were asymptomatic at the
time of ECG changes induced by the procedure
. Previous
studies (3-8) showed that during ischemia after balloon
occlusion, ECG abnormalities occurred 15 to 45 s after
balloon inflation. Anginal pain is reported (3,5,7,8) to occur
from 27' to 43 s after complete vessel occlusion . In our study,
the time to ECG changes and symptoms was 27 ± 12 and
37.9 ± 16.4 s, respectively
.
endorphin levels during coronary angioplasty . Beta-
endorphin is involved in the endogenous pain-modulating
system (20-23,28-30) . Activatior of the descending system
of pain modulation by opiates inhibits nociceptive dorsal
horn neurons, producing analgesia (20,23,28); local actions
of opiates at the spinal level also influence pain (29) . A more
complex endorphin-mediated modulation of pain seems to
occur in analgesia related to environmental, attention and
conditioning factors (22,30) .
Although still controversial, there is evidence that beta-
endorphin plasma levels play an important role in determin-
ing anginal symptoms in patients with coronary artery dis-
ease (24-26). In some studies (25,31) using the opioid
antagonist naloxone, symptoms appeared earlier than those
reported for the first time, whereas other studies (32,33)
failed to show such differences in patients with coronary
artery disease . Some investigators (33) have found no signif-
icant differences in endogenous opiate levels in symptomatic
and asymptomatic groups during exercise-induced ischemia .
However, a negative correlation was observed be , Neen
postexercise beta-endorphin plasma levels and the duration
and occurrence of angina (24). In a previous study in our
own center (26), the evaluation of 74 men with reproducible
exercise-induced ischemia revealed higher baseline plasma
levels in the asymptomatic group . A nonstringent selection
of patients in the various studies may explain the heteroge .
us nature of the data reported, when completely asymp-
tomatic patients were considered, the difference in the
id values became evident .
In this study, the beta-endorphin plasma levels deter-
mined over 2 consecutive days were consistent in patients
with silent and symptomatic angioplasty-induced ischemia,
indicating short-term stability in individual levels . Although
psychol stress is known to cause variations in beta-
endorphin plasma levels (34), the angioplasty procedure
probably did not represent a source of additional severe
stress for patients in the present study because they had had
coronary iography not long before angioplasty .
In patients who were asymptomatic during coronary
angioplasty, higher (p < 0
.001) mean baseline beta.
endorphin plasma levels were observed and remained signif-
icantly higher in these patients during and after the proce-
dure as compared with levels in symptomatic patients .
During a lasty, beta-endorphin plasma levels decreased
significantly only in the symptomatic group . In healthy
subjects, the endorphin profile did not show any significant
Variation with a noxious stimulus, as de,nunstrated by
collateral finding in our laboratory .
Although cardiovascular functions may influence the
mechanisms involved in the control of pain sensation (35-
40), blood pressure and heart rate were similar during the
procedure in the two groups . The reason for the opioid
reduction found at balloon occlusion is unknown . Coronary
angiopkasty is a very short stressor and the decrease in
beta-endorphin plasma levels observed in most patients may
be caused by an immediate increase in demand and uptake at
receptor sites . These results su est that the reduction in
circulating opioids may provoke pain in the symptomatic
group or, more li" .-ly, that receptor uptake of beta-
endorphins is accentuated in the presence of anginal symp-
toms . Differences in the regulation and metabolism of beta-
endorphins have also been related to the presence of chronic
pain (40,41) . In this study, the symptomatic patients had a
greater instability in beta-endorphin plasma levee :,, as shown
by the significant variations that occurred in group 1,
whereas the patients with silent ischemia showed more
stable values during the procedure .
Intensity of the ischemic stimuli. Although it has been
reported (11,13,15,16) that the presence of angina correlates
with the duration and degree of ischernia, similar duration of
balloon inflations has been reported (7) in patients with silent
and symptomatic coronary angioplasty-induced ischemia . In
our study, the number of balloon inflations, the inflation time
and inflation pressure during angioplasty did not differ
between patients with and without symptoms . The severity
and distribution of coronary artery disease were also similar.
The similarity of the methodologic variables used during
the procedure with different symptom outcome and degrees
of ECG changes confirms that the intensity of the stimulus is
not a determinant in provoking anginal pain. In this study,
the subgroup of asymptomatic patients had greater ST
segment deviation during coronary angioplasty, whereas
previous publications (2,7) showed similar ECG abnormali-
ties in patients with and without symptoms .
Coronary angioplasty-induced versus exercise-induced
ischentia characteristics . In our study, the prevalence of
coronary angioplasty-induced silent myocardial ischemia
(38%®) was lower than that induced by exercise (57%) . During
coronary angioplasty, the ECG changes were associated
with chest pain in 33% of the patients who were asymptom-
atic during exercise-induced ischemia, and all patients (ex-
cept one) with symptoms at the ergometric test were also
symptomatic during coronary angioplast ; , . Ai least initially,
exercise-related myocardial ischemia invs elves only suben-
docardial layers . In contrast, coronary angioplasty more
frequently provokes transmural myocardial ischemia. The
stronger ischemic stimulus of coronary angioplasty, repre-
sented by balloon occlusion, may have been the cause of the
appearance of symptoms in those patients who were asymp-
tomatic during exercise. Thus, in individual patients, the
intensity of the ischemic stimulus seems to be relevant .
Because blood pressure values were higher at peak exercise
than -t~21non occlusion, the baroceptor regulatory
system might also have played a role in the higher preva-
3ACC Vol. 22, No . 6
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lence of silent Pschemia during exercise . However, in 39 .6%
of patients, no angina was provoked either by exercise or by
coronary angioplasty-induced ischernia, suggesting that
some patients are likely not to have symptoms no matter
how severe the OWN
Anginal symptoms and sensitivity to pain . The importance
of the individual's attitude to various forms of pain has
already been pointed out . Patients with silent ischemia are
less prone to complain of experimentally induced pain (for
example, electrical skin stimulation, cold pressor test, mod-
ified submaximal effort tourniquet test and dental pulp
stimulation) than are patients who are usually symptomatic
(17-19),
The results of this study confirm an individual trend in
pain perception and, in particular, indicate that a patient's
report of anginal pain during exercise and coronary angio-
plasty tends to be constantly predictable for a given patient
and may be related to individual characteristics . In fact, the
great majority of the patients without symptoms during
balloon occlusion also had no symptoms during exercise-
induced ischenia . Moreover, the history of anginal pain was
more frequent in the subgroup of patients who were symp-
tomatic during exercise and coronary angioplasty, whereas
patients with silent ischemia were less likely to report pain
during everyday life .
A great number of central and peripheral mediators have
been recognized in the modulation of pain, including endor-
phins, metenkephalins, serotonin, gamma-aminobutyric
acid, catecholamines, adenosine and any other peptide or
molecule that can influence the complex afferent and efferent
pathways of pain perception (23) . A link between cardiovas-
cular regulation and endorphin-related hypalgesia has been
recognized and also seems of relevance in the perception of
anginal symptoms (35-40) .
In our study, asymptomatic patients were found to have
higher beta-endorphin plasma levels than those of their
symptomatic counterparts not only at rest, but also during
and after coronary angioplasty-induced ischemia in the
presence of similar blood pressure and heart rate values . In
addition, the baseline opiate levels in patients without symp-
toms at both angioplasty and exercise were the highest ;
patients with pain only at angioplasty (or exercise tolerance
testing) also had higher values than the subgroup with
anginal symptoms during both procedures . These results
confirm a primary role of circulating opioids in anginal pain
perception. Moreover, the symptomatic patients had a
greater instability in beta-endorphin plasma levels as shown
by the significant reduction at the onset of symptoms during
coronary angioplasty ; in contrast, the patients with silent
ischemia showed more stable values during the procedure .
Conclusions. The important factors for the occurrence of
pain during ischemia may be not only absolute beta-
endorphin plasma levels, but also their variations ; opiate
levels and their variability may represent the individual
characteristic associated with the attitude to anginal pain
sensation .
FALCONE ET AL
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